19 results were returned
On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").
Our international IP team are thrilled to announce the promotion of 3 new partners today. These promotions reflect our ongoing commitment to ensure the diversity of our team develops to reflect the rich pool of talent ...
On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...
In this article, we touch upon the favorable IP regime, which, provides for specific research exemptions under patent law.
The Patents Court has considered enablement in relation to anticipation of a claimed monoclonal antibody invention by prior art, and held the patent was invalid for lack of novelty; it was also obvious for lack of ...
The Patents Court has rejected a public interest defence and granted an injunction, following a finding that patents for a medical device were valid and infringed.
The Supreme Court has held that two patents for a transgenic mouse used for the development of human antibodies were invalid for insufficiency.